Long-term outcomes of neoadjuvant nivolumab plus chemotherapy in resectable NSCLC in Japanese patients: final 5-year follow-up analysis from CheckMate 816
Long-term outcomes of neoadjuvant nivolumab plus chemotherapy in resectable NSCLC in Japanese patients: final 5-year follow-up analysis from CheckMate 816. // JAAD International. – URL: https://www.sciencedirect.com/science/article/pii/S3117504X26000409?dgcid=rss_sd_all
Long-term outcomes of neoadjuvant nivolumab plus chemotherapy in resectable NSCLC in Japanese patients: final 5-year follow-up analysis from CheckMate 816. JAAD International. https://www.sciencedirect.com/science/article/pii/S3117504X26000409?dgcid=rss_sd_all
“Long-term outcomes of neoadjuvant nivolumab plus chemotherapy in resectable NSCLC in Japanese patients: final 5-year follow-up analysis from CheckMate 816.” JAAD International.
@article{article5822,
title = {Long-term outcomes of neoadjuvant nivolumab plus chemotherapy in resectable NSCLC in Japanese patients: final 5-year follow-up analysis from CheckMate 816},
journal = {JAAD International},
url = {https://www.sciencedirect.com/science/article/pii/S3117504X26000409?dgcid=rss_sd_all}
}